Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe in the U.S. Market
HYDERABAD, IN PRINCETON, NJ, USA: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe, a therapeutic equivalent generic version of Narcan® (naloxone hydrochloride) Injection USP, approved by the U.S. Food and Drug Administration (USFDA).
“We are pleased to bring our second product to market that has been designated as a Competitive Generic Therapy (CGT) by the USFDA,” says Marc Kikuchi, Chief Executive Officer, North America Generics, Dr. Reddy’s Laboratories. “With a CGT designation, we have 180-day CGT exclusivity to market this product.”
The Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) had U.S. sales of approximately $31 million MAT for the most recent twelve months ending in January 2020 according to IQVIA Health*.
Dr. Reddy’s Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) is available in 2 mL single-dose prefilled syringe.
Please see full prescribing information https://www.drreddys.com/pi/Naloxone_Hydrochloride_Injection_PI.pdf
NARCAN® is a trademark of ADAPT Pharma Operations Limited
*IQIA Retail and Non-Retail MAT January 2020 RDY-0320-282
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Sign me up for the newsletter!
Notify me of follow-up comments by email.
Notify me of new posts by email.
Anil Rawal appointed as the Chief Executive Officer of IntelliSmart
McDonald’s India introduces a unique ‘Work from Home’ policy for its Restaurant Management Team and Frontline Crew
Sony Pictures Networks (SPN) pledges INR 100 million to Film and Television industry daily wage earners affected by unemployment during the COVID-19 pandemic
Here’s how CD Leganes continue training with LaLiga suspended and Spain in lockdown
Myntra partners with Wildcraft to offer personal protective face masks on its platform
2014 The Global Indian New Network (TGINN)